The Recall Desk
SevereFDA (Drugs)·D-0397-2026·Announced 2026-03-11

MR. 7 Super capsules recalled as Class I over undeclared sildenafil

StuffbyNainax is recalling MR. 7 SUPER 700000 capsules because FDA analysis revealed the presence of undeclared sildenafil and tadalafil. The FDA has classified this recall as Class I.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The rubric states an FDA Class I recall is never scored below 4, and this record carries a Class I classification with no reported deaths in the source.

Plain-English summary

StuffbyNainax is recalling MR. 7 SUPER 700000 capsules, supplied as a one-capsule blister card, distributed by mR. 7. Four units were distributed to four customers in the United States.

The product was marketed without an approved New Drug Application or Abbreviated New Drug Application, and FDA analysis revealed the presence of undeclared sildenafil and tadalafil. The FDA has classified this recall as Class I, its most serious category.

All codes are affected, with an expiry date of 12/31/2029.

Consumers can identify affected product by the product name and expiry date above, and may contact StuffbyNainax for further information.

The recalled product

Product
MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7
Manufacturer
StuffbyNainax
Category
Drug — Dietary supplement
Hazard
Affected units
4

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • All codes
  • Exp 12/31/2029

Distribution

Distribution scope not specified by the agency.

Related recalls

Same hazard · undeclared ingredient

See all →